{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:34:18Z","timestamp":1771954458046,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01HL10715301"],"award-info":[{"award-number":["P01HL10715301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bbrc.2015.07.159","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T23:00:47Z","timestamp":1438729247000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"465","author":[{"given":"Sumita","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djahida","family":"Bedja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Amuzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subroto","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.bbrc.2015.07.159_bib1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2015.07.159_bib2","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1152\/ajprenal.2000.278.1.F63","article-title":"Oxidant stress in hyperlipidemia-induced renal damage","volume":"278","author":"Scheuer","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.bbrc.2015.07.159_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0002-9149(00)01004-3","article-title":"Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension","volume":"86","author":"Su","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbrc.2015.07.159_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.bbrc.2015.07.159_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.103.6.836","article-title":"Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later","volume":"103","author":"Sundstrom","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bbrc.2015.07.159_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study","volume":"108","author":"Levy","year":"1988","journal-title":"Ann. Intern Med."},{"issue":"2","key":"10.1016\/j.bbrc.2015.07.159_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","article-title":"Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective","volume":"25","author":"Alexander","year":"1995","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bbrc.2015.07.159_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","article-title":"Oxidative stress and vascular disease","volume":"25","author":"Madamanchi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2015.07.159_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI108079","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle","volume":"56","author":"Grossman","year":"1975","journal-title":"J.\u00a0Clin. Invest."},{"issue":"12","key":"10.1016\/j.bbrc.2015.07.159_bib10","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","article-title":"Vascular calcification mechanisms","volume":"15","author":"Giachelli","year":"2004","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"63","key":"10.1016\/j.bbrc.2015.07.159_bib11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1098\/rsif.2011.0177","article-title":"Role of shear stress and stretch in vascular mechanobiology","volume":"8","author":"Lu","year":"2011","journal-title":"J.\u00a0R. Soc. Interface"},{"issue":"1","key":"10.1016\/j.bbrc.2015.07.159_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension","volume":"13","author":"Vaziri","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"11","key":"10.1016\/j.bbrc.2015.07.159_bib13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/CIRCULATIONAHA.104.490599","article-title":"Epidemiology of uncontrolled hypertension in the United States","volume":"112","author":"Wang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2015.07.159_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-7120-3-17","article-title":"Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?","volume":"3","author":"Foppa","year":"2005","journal-title":"Cardiovasc. Ultrasound"},{"key":"10.1016\/j.bbrc.2015.07.159_bib15","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.2741\/3213","article-title":"Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1","volume":"13","author":"Cingolani","year":"2008","journal-title":"Front. Biosci."},{"issue":"1 Pt 1","key":"10.1016\/j.bbrc.2015.07.159_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.HYP.30.1.29","article-title":"Role for endothelin-1 in angiotensin II-mediated hypertension","volume":"30","author":"Rajagopalan","year":"1997","journal-title":"Hypertension"},{"issue":"Pt 9","key":"10.1016\/j.bbrc.2015.07.159_bib17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1113\/jphysiol.2009.186619","article-title":"The Anrep effect requires transactivation of the epidermal growth factor receptor","volume":"588","author":"Villa-Abrille","year":"2010","journal-title":"J.\u00a0Physiol."},{"issue":"10","key":"10.1016\/j.bbrc.2015.07.159_bib18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.ATV.18.10.1523","article-title":"Sphingolipids in atherosclerosis and vascular biology","volume":"18","author":"Chatterjee","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bbrc.2015.07.159_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/glycob\/cwu020","article-title":"Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1\/2 in cardiomyocytes","volume":"24","author":"Mishra","year":"2014","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.bbrc.2015.07.159_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbagen.2007.08.010","article-title":"The Yin and Yang of lactosylceramide metabolism: implications in cell function","volume":"1780","author":"Chatterjee","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"23","key":"10.1016\/j.bbrc.2015.07.159_bib21","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.113.007559","article-title":"Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E\u2212\/\u2212 mice and rabbits fed a high-fat and -cholesterol diet","volume":"129","author":"Chatterjee","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bbrc.2015.07.159_bib22","doi-asserted-by":"crossref","first-page":"R1067","DOI":"10.1152\/ajpregu.00124.2011","article-title":"Renal proximal tubule angiotensin AT1A receptors regulate blood pressure","volume":"301","author":"Li","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"8","key":"10.1016\/j.bbrc.2015.07.159_bib23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A\u00a0rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"issue":"7","key":"10.1016\/j.bbrc.2015.07.159_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/glycob\/cwp047","article-title":"Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase","volume":"19","author":"Zama","year":"2009","journal-title":"Glycobiology"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15303880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15303880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T02:19:46Z","timestamp":1567045186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15303880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0006291X15303880"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.159","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE\u2212\/\u2212 mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}